UA83528C2 - Плазма крови, полученная от доноров, не относящихся к европеоидной расе, и ее применение - Google Patents

Плазма крови, полученная от доноров, не относящихся к европеоидной расе, и ее применение Download PDF

Info

Publication number
UA83528C2
UA83528C2 UAA200608016A UAA200608016A UA83528C2 UA 83528 C2 UA83528 C2 UA 83528C2 UA A200608016 A UAA200608016 A UA A200608016A UA A200608016 A UAA200608016 A UA A200608016A UA 83528 C2 UA83528 C2 UA 83528C2
Authority
UA
Ukraine
Prior art keywords
aai
blood
ebiaz
ivasiv
ebia
Prior art date
Application number
UAA200608016A
Other languages
English (en)
Ukrainian (uk)
Inventor
Андреа Хегер
Юрген Рьомиш
Тор-Эйнар Швае
Вольфганг Маргерре
Original Assignee
Октафарма Аг
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Октафарма Аг filed Critical Октафарма Аг
Publication of UA83528C2 publication Critical patent/UA83528C2/ru

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C01—INORGANIC CHEMISTRY
    • C01G—COMPOUNDS CONTAINING METALS NOT COVERED BY SUBCLASSES C01D OR C01F
    • C01G23/00—Compounds of titanium
    • C01G23/04—Oxides; Hydroxides
    • C01G23/047—Titanium dioxide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/14—Blood; Artificial blood
    • A61K35/16—Blood plasma; Blood serum
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/25—Silicon; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
    • A61K8/29—Titanium; Compounds thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/08—Plasma substitutes; Perfusion solutions; Dialytics or haemodialytics; Drugs for electrolytic or acid-base disorders, e.g. hypovolemic shock
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B82—NANOTECHNOLOGY
    • B82B—NANOSTRUCTURES FORMED BY MANIPULATION OF INDIVIDUAL ATOMS, MOLECULES, OR LIMITED COLLECTIONS OF ATOMS OR MOLECULES AS DISCRETE UNITS; MANUFACTURE OR TREATMENT THEREOF
    • B82B3/00—Manufacture or treatment of nanostructures by manipulation of individual atoms or molecules, or limited collections of atoms or molecules as discrete units

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • General Health & Medical Sciences (AREA)
  • Hematology (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cell Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Inorganic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Virology (AREA)
  • Zoology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Biotechnology (AREA)
  • Birds (AREA)
  • Immunology (AREA)
  • Nanotechnology (AREA)
  • Manufacturing & Machinery (AREA)
  • Environmental & Geological Engineering (AREA)
  • General Life Sciences & Earth Sciences (AREA)
  • Geology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • External Artificial Organs (AREA)

Abstract

Изобретение относится к плазме крови, полученной от доноров, из которых 10 % или более не принадлежат к европеоидной расе, при этом плазма получена путем смешивания крови или плазмы крови групп крови А и В, и необязательно АВ без добавления существенных количеств крови или плазмы крови группы 0.
UAA200608016A 2003-12-19 2004-12-20 Плазма крови, полученная от доноров, не относящихся к европеоидной расе, и ее применение UA83528C2 (ru)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP03029359 2003-12-19
PCT/EP2004/053608 WO2005058334A1 (en) 2003-12-19 2004-12-20 A universally applicable virus inactivated blood plasma produced from portions of non-caucasian plasma

Publications (1)

Publication Number Publication Date
UA83528C2 true UA83528C2 (ru) 2008-07-25

Family

ID=34684548

Family Applications (1)

Application Number Title Priority Date Filing Date
UAA200608016A UA83528C2 (ru) 2003-12-19 2004-12-20 Плазма крови, полученная от доноров, не относящихся к европеоидной расе, и ее применение

Country Status (23)

Country Link
US (2) US20070071829A1 (ru)
EP (1) EP1696940B1 (ru)
JP (1) JP2007514716A (ru)
KR (1) KR101077976B1 (ru)
CN (1) CN1893960B (ru)
AT (1) ATE357242T1 (ru)
AU (1) AU2004298790B2 (ru)
BR (1) BRPI0417680A (ru)
CA (1) CA2550060A1 (ru)
CY (1) CY1106661T1 (ru)
DE (1) DE602004005501T2 (ru)
DK (1) DK1696940T3 (ru)
ES (1) ES2281848T3 (ru)
IL (1) IL175558A0 (ru)
NO (1) NO20062360L (ru)
PL (1) PL1696940T3 (ru)
PT (1) PT1696940E (ru)
RS (1) RS50508B (ru)
RU (1) RU2362571C2 (ru)
SI (1) SI1696940T1 (ru)
UA (1) UA83528C2 (ru)
WO (1) WO2005058334A1 (ru)
ZA (1) ZA200604941B (ru)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1958618A1 (de) 2007-02-15 2008-08-20 Octapharma AG Verfahren zur Gefriertrocknung mit optimierter Rekonstitution von Biopolymeren
FR2963737B1 (fr) * 2010-08-16 2013-04-05 Etat Francais Ministere De La Defense Service De Sante Des Armees Procede de lyophilisation de plasma sanguin
EP3093035A1 (en) 2015-05-13 2016-11-16 Sanofi-Aventis Deutschland GmbH Injection device for delivery of a liquid medicament
CN107496453A (zh) * 2017-08-13 2017-12-22 发贵科技（贵州）有限公司 一种有病毒灭活功能的血浆抗凝剂

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4664913A (en) * 1982-05-24 1987-05-12 Xoma Corporation Method for treating plasma for transfusion
US4764369A (en) * 1983-07-14 1988-08-16 New York Blood Center Inc. Undenatured virus-free biologically active protein derivatives
US5217627A (en) * 1990-11-06 1993-06-08 Pall Corporation System and method for processing biological fluid
AU667530B2 (en) * 1992-05-28 1996-03-28 New York Blood Center, Inc., The Removal of antibodies from blood-derived compositions while retaining coagulation factors
EP0896824A1 (en) * 1997-08-05 1999-02-17 Octapharma Ag A universally applicable blood plasma
CN1207004C (zh) * 2001-04-18 2005-06-22 马建川 通用型冻干血浆及其制备方法
US20030133829A1 (en) * 2001-12-21 2003-07-17 Baxter Healthcare Corporation Process for inactivating pathogens in a biological material

Also Published As

Publication number Publication date
DE602004005501D1 (de) 2007-05-03
US20070071829A1 (en) 2007-03-29
KR20060126662A (ko) 2006-12-08
IL175558A0 (en) 2006-09-05
EP1696940A1 (en) 2006-09-06
SI1696940T1 (sl) 2007-08-31
NO20062360L (no) 2006-05-23
US20110104298A1 (en) 2011-05-05
AU2004298790A1 (en) 2005-06-30
ZA200604941B (en) 2007-11-28
RS50508B (sr) 2010-03-02
PL1696940T3 (pl) 2007-08-31
AU2004298790B2 (en) 2010-04-08
ES2281848T3 (es) 2007-10-01
CA2550060A1 (en) 2005-06-30
RU2362571C2 (ru) 2009-07-27
DK1696940T3 (da) 2007-07-30
PT1696940E (pt) 2007-05-31
CY1106661T1 (el) 2012-05-23
JP2007514716A (ja) 2007-06-07
CN1893960B (zh) 2012-10-31
BRPI0417680A (pt) 2007-03-20
ATE357242T1 (de) 2007-04-15
WO2005058334A1 (en) 2005-06-30
DE602004005501T2 (de) 2007-11-29
CN1893960A (zh) 2007-01-10
RU2006126055A (ru) 2008-01-27
EP1696940B1 (en) 2007-03-21
KR101077976B1 (ko) 2011-10-28

Similar Documents

Publication Publication Date Title
UA83528C2 (ru) Плазма крови, полученная от доноров, не относящихся к европеоидной расе, и ее применение
WO2006002245A3 (en) Variation of image content in electronic messaging protocol messages
Cho et al. Prokaryotic abundance and 16S rRNA gene sequences detected in marine aerosols on the East Sea (Korea)
EP2515490A3 (en) Systems and methods for network routing in a multiple backbone network architecture
EP1670196A3 (en) Reliably transferring queued application messages
TW200744650A (en) Oral compositions comprising propolis
EP1309067A3 (en) Permanent magnet retaining arrangement for high speed rotors
RU2011152950A (ru) Композиция зубной пасты
EP1253770A3 (en) System for sending group announcements
MY144188A (en) Control of kinetic decomposition in mixed conducting ion transport membranes
BR112012027179A2 (pt) composições de higiene bucal resistentes ao crescimento microbiano
BR0203985A (pt) Composições de formação de pelìcula contendo sucralose
HK1111090A1 (en) Oral osmotic dosage form having a high flux membrane
WO2008078218A3 (en) Methods for providing feedback in messaging systems
Tapping et al. Lean office demystified
AU2021377272A9 (en) Enriched bioactive renal cell populations, characteristics and uses thereof
EP1524559A3 (en) Hydrodynamic bearing apparatus and stage apparatus using the same
JP2022083961A5 (ru)
TW200604887A (en) Message management system and method
Aim et al. Membranes and the Environment: A special C 3 post-ICOM workshop in honour of Roger
Schmidt Sabo En senvikingatida storgård i Hjärup, Skåne: nya analysresultat
de Sanz Untitled manuscript, addressed to" Hermanos"[incomplete manuscript]
Cidonio 14 A Free Piece of Cake
Haoran et al. Self-organization of swimmers drives long-range fluid transport in bacterial colonies
ATE513431T1 (de) Verfahren zur vernetzung einer mehrzahl von konvergenten messaging systemen und entsprechendes netzsystem